Literature DB >> 25769893

A network pharmacology study of Sendeng-4, a Mongolian medicine.

Tian Zi1, Dong Yu2.   

Abstract

We collected the data on the Sendeng-4 chemical composition corresponding targets through the literature and from DrugBank, SuperTarget, TTD (Therapeutic Targets Database) and other databases and the relevant signaling pathways from the KEGG (Kyoto Encyclopedia of Genes and Genomes) database and established models of the chemical composition-target network and chemical composition-target-disease network using Cytoscape software, the analysis indicated that the chemical composition had at least nine different types of targets that acted together to exert effects on the diseases, suggesting a "multi-component, multi-target" feature of the traditional Mongolian medicine. We also employed the rat model of rheumatoid arthritis induced by Collgen Type II to validate the key targets of the chemical components of Sendeng-4, and three of the key targets were validated through laboratory experiments, further confirming the anti-inflammatory effects of Sendeng-4. In all, this study predicted the active ingredients and targets of Sendeng-4, and explored its mechanism of action, which provided new strategies and methods for further research and development of Sendeng-4 and other traditional Mongolian medicines as well.
Copyright © 2015 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disease pathway networks; Drug targeting; In vivo evaluation; Mongolian medicine; Network pharmacology; Rheumatoid arthritis; Sendeng-4

Mesh:

Substances:

Year:  2015        PMID: 25769893     DOI: 10.1016/S1875-5364(15)60014-0

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  2 in total

1.  K Nearest Neighbor Algorithm Coupled with Metabonomics to Study the Therapeutic Mechanism of Sendeng-4 in Adjuvant-Induced Rheumatoid Arthritis Rat.

Authors:  Xiye Wang; Dan Li; Mingyang Jiang; Zhili Pei; Liang Xu
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-22       Impact factor: 2.629

2.  The Potential Mechanism of Wuwei Qingzhuo San against Hyperlipidemia Based on TCM Network Pharmacology and Validation Experiments in Hyperlipidemia Hamster.

Authors:  Jianliang Li; Chaolu Wang; Lin Song; Shuzhen Cai; Zhiyong Li; Ya Tu
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-10       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.